Study of Aripiprazole in Patients With a History of Bipolar Disorder
Public ClinicalTrials.gov record NCT00036348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.
Study identification
- NCT ID
- NCT00036348
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2000 (Type not available)
- Primary completion
- Jun 2003 (Actual)
- Completion
- Jun 2003 (Actual)
- Last update posted
- Nov 11, 2013
2000 – 2003
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Tuscaloosa | Alabama | — | — |
| Local Institution | Chillicothe | California | — | — |
| Local Institution | Riverside | California | — | — |
| Local Institution | Stanford | California | — | — |
| Local Institution | Torrance | California | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Shreveport | Louisiana | — | — |
| Local Institution | Belmont | Massachusetts | — | — |
| Local Institution | Las Vegas | Nevada | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Nashville | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00036348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2013 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00036348 live on ClinicalTrials.gov.